Shorter radiation for poor-prognosis GBM
Part of Cancer clinical trials.
This trial tests a shorter course of radiation (hypofractionated RT) for people with a specific type of aggressive brain tumor (GBM) that is not suitable for surgery. It aims to see if this shorter treatment can be effective with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of brain tumor called glioblastoma (GBM), confirmed by a biopsy or MRI.
- Your tumor does not have a mutation in the IDH gene.
- Your Neurological Predictor Scale (NPS) score is 2 or 3 (moderate neurological issues).
- You are 50 years old or older.
- You are not able to have surgery and are being referred directly for radiation therapy.
- You have not had any other treatments for your tumor, like chemo or targeted drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, shorter course of radiation therapy (called hypofractionation) for people with glioblastoma that has come back. It is for patients who have already had radiation and are doing well enough to consider another round.
This trial tests a shorter course of radiation therapy combined with the chemotherapy drug temozolomide for people with glioblastoma. It aims to see if this approach works as well as standard treatment while being more convenient.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
This trial tests a type of radiation therapy that uses a smaller, more focused area on the brain after surgery for glioblastoma. The goal is to see if this approach can reduce side effects while still controlling the tumor.
This trial tests a smaller radiation target for newly diagnosed glioblastoma to reduce side effects while keeping treatment effective. It may help patients who are healthy enough for standard chemoradiotherapy.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.